Swissmedic examines drugs trialled by GVK Biosciences
The Swiss surveillance authority for medicines Friday checked for any corresponding preparations of the 700 generic medicines subjected to clinical trials by India's GVK Biosciences, whose marketing rights were suspended by the European Medicines Agency (EMA).
Feb 07, 2015, 00:59 AM IST